Subjects: A2AR?DDM, DDM-solubilized A2AR, HEK, human embryonic kidney, GPCR, G-protein coupled receptor, FTICR, Fourier-transform ion cyclotron resonance, NECA, 5'-(N-ethylcarboxamido)adenosine, PTH1R, parathyroid hormone 1 receptor, SMALP, SMA lipid particle, AUC, analytical ultracentrifugation, Original Paper, MSP, membrane scaffold protein, structure, A2AR?SMALP, SMALP-solubilized A2AR, cv, column volumes, G-protein coupled receptor (GPCR), DDM, n-dodecyl-?-D-maltopyranoside, adenosine receptor, protein thermostability, A2AR, adenosine A2A receptor, SMA, styrene maleic acid, XAC, xanthine analogue congener, detergent-free, NTA, nitrilotriacetate
Classified by OpenAIRE into
G-protein coupled receptors (GPCRs) constitute the largest class of membrane proteins and are a major drug target. A serious obstacle to studying GPCR structure/function characteristics is the requirement to extract the receptors from their native environment in the plasma membrane, coupled with the inherent instability of GPCRs in the detergents required for their solubilization. In the present study, we report the first solubilization and purification of a functional GPCR [human adenosine A2A receptor (A2AR)], in the total absence of detergent at any stage, by exploiting spontaneous encapsulation by styrene maleic acid (SMA) co-polymer direct from the membrane into a nanoscale SMA lipid particle (SMALP). Furthermore, the A2AR-SMALP, generated from yeast (Pichia pastoris) or mammalian cells, exhibited increased thermostability (∼5°C) compared with detergent [DDM (n-dodecyl-β-D-maltopyranoside)]-solubilized A2AR controls. The A2AR-SMALP was also stable when stored for prolonged periods at 4°C and was resistant to multiple freeze-thaw cycles, in marked contrast with the detergent-solubilized receptor. These properties establish the potential for using GPCR-SMALP in receptor-based drug discovery assays. Moreover, in contrast with nanodiscs stabilized by scaffold proteins, the non-proteinaceous nature of the SMA polymer allowed unobscured biophysical characterization of the embedded receptor. Consequently, CD spectroscopy was used to relate changes in secondary structure to loss of ligand binding ([3H]ZM241385) capability. SMALP-solubilization of GPCRs, retaining the annular lipid environment, will enable a wide range of therapeutic targets to be prepared in native-like state to aid drug discovery and understanding of GPCR molecular mechanisms.